Explore how brain insulin resistance may underlie Alzheimer’s, linking metabolic dysfunction to cognitive decline.

Discover the potential of microdosing GLP-1 for weight loss, inflammation, cognitive health, and more.

GLP-1 receptor agonists show promise in Alzheimer’s disease prevention, offering benefits beyond weight loss and diabetes management.

Explore top insights from A4M’s Longevity Conference, including neurotransmitter health, vagus nerve stimulation, GLP-1 therapy, and cellular longevity.